Cargando…
The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD
Monoamine oxidase (MAO) has been implicated in neuroinflammation, and therapies targeting MAO are of interest for neurodegenerative diseases. The small-molecule drug tranylcypromine, an inhibitor of MAO, is currently used as an antidepressant and in the treatment of cancer. However, whether tranylcy...
Autores principales: | Park, HyunHee, Han, Kyung-Min, Jeon, Hyongjun, Lee, Ji-Soo, Lee, Hyunju, Jeon, Seong Gak, Park, Jin-Hee, Kim, Yu Gyung, Lin, Yuxi, Lee, Young-Ho, Jeong, Yun Ha, Hoe, Hyang-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563969/ https://www.ncbi.nlm.nih.gov/pubmed/32872335 http://dx.doi.org/10.3390/cells9091982 |
Ejemplares similares
-
L-Type Ca(2+) Channel Inhibition Rescues the LPS-Induced Neuroinflammatory Response and Impairments in Spatial Memory and Dendritic Spine Formation
por: Kim, Jieun, et al.
Publicado: (2022) -
Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD
por: Han, Kyung-Min, et al.
Publicado: (2020) -
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020) -
Sorafenib Modulates the LPS- and Aβ-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice
por: Kim, Jieun, et al.
Publicado: (2021) -
Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling
por: Ryu, Ka-Young, et al.
Publicado: (2019)